.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Baxter
McKesson
Mallinckrodt
Boehringer Ingelheim
Novartis
Federal Trade Commission
Chinese Patent Office
Queensland Health
Covington

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 5,690,958 protect, and when does it expire?


Patent ► Subscribe protects CHLORAPREP ONE-STEP, CHLORAPREP ONE-STEP FREPP, CHLORAPREP WITH TINT, and CHLORAPREP ONE-STEP SEPP, and is included in two NDAs.

This patent has fourteen patent family members in twelve countries.

Summary for Patent: ► Subscribe

Title: Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life
Abstract:A unit dose chlorhexadine gluconate (CHG) applicator is disclosed wherein a unit dose of the CHG is contained in a hermetically sealed manually crushable glass ampule that has an internal volume not significantly greater than the unit dose volume of the CHG. The CHG in the ampule has an effective shelf life of at least 24 months. The glass ampule of the applicator is preferably protected by a flexible cover to protect the user's hand during manual crushing of the ampule to release the CHG therefrom. In one embodiment of the invention, a cylindrical glass ampule is housed within a tubular, flexible synthetic resin cover which has a porous applicator swab at one end thereof. Upon crushing of the glass ampule, the CHG released therefrom impregnates the swab allowing the user to spread the CHG across an area to be sanitized. In a second embodiment of the invention, a cylindrical glass ampule is received within a semi-cylindrical, open-sided body cover having a flange portion that mounts a sponge-like swab communicating with the interior of the body cover. Opposed integral wing-like gripping members on the ampule permit the user to crush the ampule by squeezing the members toward one another whereupon the CHG is released from the ampule and impregnates the sponge swab. The swab soaked with the CHG antiseptic may be rubbed across an area to be sanitized.
Inventor(s): McGrath; Patrick D. (Lenexa, KS)
Assignee: Medi-Flex Hospital Products, Inc. (Overland Park, KS)
Application Number:08/723,686
Patent Claim Types:
see list of patent claims
Delivery; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Becton Dickinson Co
CHLORAPREP ONE-STEP
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-001Jul 14, 2000OTCYesYes► Subscribe► SubscribeY
Becton Dickinson Co
CHLORAPREP ONE-STEP
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-004Aug 20, 2003OTCYesYes► Subscribe► SubscribeY
Becton Dickinson Co
CHLORAPREP ONE-STEP
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-006Nov 21, 2006OTCYesYes► Subscribe► SubscribeY
Becton Dickinson Co
CHLORAPREP ONE-STEP FREPP
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-003Apr 26, 2002OTCYesYes► Subscribe► SubscribeY
Becton Dickinson Co
CHLORAPREP WITH TINT
chlorhexidine gluconate; isopropyl alcohol
SPONGE;TOPICAL020832-002May 3, 2005OTCYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
New Zealand334273► Subscribe
Spain2230615► Subscribe
European Patent Office0929296► Subscribe
Germany69728280► Subscribe
Japan2000507478► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Colorcon
Boehringer Ingelheim
Express Scripts
Federal Trade Commission
Cipla
Medtronic
Cantor Fitzgerald
UBS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot